Ask for a monthly pass, ask for a subscription, ask for a recommendation!

************

Hearing Hu Xuefeng say this, Jin Muchen probably had a bottom in his heart.

This Scott is not the kind of idiot who doesn't know anything but scientific research, and it can be seen from the direction of scientific research he chooses that this is a very business-minded person.

The investment report that Jin Muchen saw from Harvey said that the amount of their financing this time was 3 million, and the shares of the institute that were given up were only 10%.

This shows that they attach great importance to their scientific research results, and they are also very optimistic about the application of this achievement in the market in the future.

After learning about their results, Jin Muchen also held the same opinion, indeed femoral head necrosis, and other bone and joint replacement surgeries, in the world's medical scope, do not occupy a very large scope in the medical field.

Compared with those traditional diseases, such as three highs, cancer, etc., this disease is not a major disease, and there are many alternative treatments.

But if they put their research results on the market, it would be amazing, and with the increase in cases and changes in people's eating habits in recent years, their medical results represent a very potential growth market.

This is a long-term promising project, and the team is not a fool, so of course it is not willing to give up too much stake.

But for investors like Mr. Jin, this is not a good thing.

After all, as an outside investor, of course he wants to maximize his interests, 10% of the shares, in his opinion, is too little, of course he wants more, in fact, 30% or 40%. More than half of the truth is his ideal goal.

If you don't ask Hu Xuefeng today, if he doesn't know the general bottom line of the other party, then he will have a talk with Na Scott in a few days.

But if you know the bottom line of the other party, then you can increase the weight on your side.

Jin Muchen had already gotten what he wanted to know from Hu Xuefeng, and he didn't ask Hu Xuefeng much about the laboratory after that.

The two chatted about some daily life or something. The atmosphere is very harmonious, and Jin Muchen also has high hopes for this kid.

In fact, he hopes that this Hu Xuefeng can grow smoothly and gain a foothold in this laboratory, because he needs an agent in this laboratory in the future.

Three days later, Jin Muchen and Harvey came to Scott's lab with their prepared contract.

After the two sides sat down, Xavi smiled and pushed the contract in his hand, and Scott picked it up and looked at it. Immediately, his face changed.

"Hmm...... Mr. Kim, I have to say that your proposal is very ...... Challenging...... Well, I'll need to talk to my team about it, and rest assured, I should get back to you soon. ”

"Okay, no problem, I can afford to wait."

Jin Muchen said with a smile. In fact, the conditions he gave can be said to be quite generous.

He accepted the other party's request for three million and 10 percent of the shares. However, he added a number of clauses later.

That is the future project, he will continue to make additional investment, depending on the progress and needs of the laboratory, if the knee joint trial project is completed, after the results are achieved, he will make an additional investment of 2 million. It will account for 20% of the laboratory's shares.

In the future, it will be seen that the needs of the laboratory will increase the investment again, and the fixed amount of the first phase of the contract, he will eventually increase the investment amount as high as 10 million US dollars.

And when his investment reaches this amount, his stake in the laboratory will increase to 40%.

After that. If there is a need in the laboratory, of course, he can continue to make additional investments, and of course, with the increase of funds, his share of the laboratory will also increase accordingly.

But in the first phase, this 10 million, up to 40% of the shares, is actually very cost-effective.

Moreover, when the laboratory has financing needs in the future, he must have a series of proviso terms and conditions that are more beneficial to him than other funds, investors, etc.

Scott and his team soon had a heated discussion about the contract they had brought with him in an office outside the conference room.

They only wanted to raise 3 million, but when they thought that they were willing to contribute 10 million, this was not a small amount of money.

And they are just a laboratory, not the kind of Internet companies that have the potential to make money in the NASDAQ business circle at any time, in fact, investing in medical research institutions like them is very risky.

First of all, the investment cycle is long and the risk is high, and the final failure rate is high and the yield rate is low, which is the main reason why it is difficult for a small research institute like theirs to raise funds.

It is not for nothing that they have early results, but they only dare to ask for 3 million in financing, and give 10% of the shares.

Because small research institutes like theirs are not 1,000 or 800 in the United States, and the output rate of those large and famous medical research institutions is not comparable at all.

It is so easy for those large medical research institutions to want money, and every year there are countless rich people who take the initiative to donate to them, and if they are willing to transfer their shares, there are countless people who are willing to wave checks and squeeze their heads to grab them, but small medical research institutions like them do not have that kind of treatment.

Unless you have a fist product, but the problem is, now they are stuck on the eve of their fist product listing verification, and this period is also the hardest.

And even if it has passed the verification of the U.S. government, it is not so simple to promote it in the market, after all, you, an unknown junior, suddenly launched such a low-priced, high-quality product, it is going to smash the jobs of many large medical companies, and it is strange that people don't work hard with you.

So there's still a long way to go if you want to be successful.

And Jin Muchen's conditions as an investor seem to be really good, people are willing to take the initiative to provide 10 million, the most important thing is that they promise not to point fingers in the laboratory, which is very critical.

And look at the appearance of this guy, it seems that his pockets are very deep, I don't know if it's the kind of guy with unlimited funds, if it's that kind of guy, then it's good, long-term cooperation, no problem at all.

After all, most of them are experts in scientific research, and in business, they are not good at negotiating with people every day, intriguing with each other.

For that time, they prefer to hide in the lab and do a few more experiments.

So it only took half an hour for Scott and his team to agree to Jin Muchen's conditions, the contract signed by the two parties, and then Jin Muchen took out the computer and began to transfer money to the laboratory, and soon the three million funds were in place.

According to the agreement between the two parties, after the first phase of the femoral head project starts clinical trials in the hospital in California, Scott and the others will enter the second phase of the knee replacement project, and at that time, Jin Muchen's second fund will be in place immediately.

The rest is five million for the third phase, depending on how Scott and they set up the project.

After the contract was signed and the funds were in place, Jin Muchen became one of the major shareholders of this laboratory, and everyone certainly had a reason to go out to celebrate.

This time, Jin Muchen took the initiative to treat everyone and took everyone to Manhattan's Chinatown for a big meal.

But this time it really scared Jin Muchen enough, I didn't expect these guys to look like Sven Wen when they were in the laboratory, but when they arrived at the restaurant, they all looked like starving ghosts were reincarnated.

Scott alone killed a large portion of Yang@Zhou fried rice, and Jin Muchen didn't understand why these foreigners liked to eat fried rice so much, you must know that this restaurant is famous for its affordability, and the large portion of Yangzhou fried rice is served in a large bowl comparable to a basin.

Later, as soon as everyone chatted, Jin Muchen learned that these guys usually work overtime in the laboratory, and when they work overtime, they often order takeout, but the takeaway they most often call is Chinese food, because it is delicious and cheap, so Chinese food is almost everyone's favorite in their team.

Today, he, the major shareholder, invited them to come here for dinner, and of course they don't mind eating a meal from him.

Jin Muchen laughed, he didn't care, everyone reached a cooperation today, and in the future, he will be a comrade-in-arms in the trench, and everyone will earn money, this is the key.

After dealing with this project, it is actually a huge amount of money for him in the future and finding a suitable investment channel.

It's better to invest in a medical project than to get involved in something he doesn't know about.

What's more, he believes that the scientific research results of ADATA Research Institute will definitely achieve good results as long as they are listed.

Even if this achievement can't open the market in the United States, Jin Muchen has a way to introduce this thing to China, after all, his relationship with Wang Xueming is wasted if he doesn't need it.

If this thing is introduced into China, it will definitely be very popular, with low cost and low rejection, and the domestic market for bone and joint replacement is not necessarily smaller than that of North America.

It's a big deal that I'm giving away a certain profit, it's good to pull a few more people like Wang Xueming on the boat, anyway, multiple friends, multiple roads, everyone earns, is really earning.

After dealing with this investment, Jin Muchen knew that his recent work in the United States had finally come to an end.

Some time ago, he had already planned his next destination, which was Australia.

He has basically visited several large second-hand markets in the United States, but he doesn't want to go again this year, there are good things every year, not bad this year.

This time he wants to expand the overseas market, Australia is a good place for him to go, and there are not a few Chinese there, maybe he can meet something good. (To be continued......)